Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FUJRN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,532
Award facts
- Contract value 100% obligated
- $7,531.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $7,531.89 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 mL vials. EXPAREL is a liposomal bupivacaine product used for infiltration and nerve block anesthesia in surgical settings. The delivery order was awarded on August 20, 2025, with an ultimate completion date of September 11, 2025, and includes no set-aside designation. Performance will occur at the vendor's location in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a comprehensive pharmaceutical supply vehicle valued at $499,999,999 and extending through November 2026. The IDC enables DLA to issue firm fixed-price delivery orders for an extensive range of pharmaceutical products supporting medical supply needs across military health facilities worldwide. DMS Pharmaceutical Group has established itself as a key supplier in the federal pharmaceutical supply chain, with a consistent portfolio of contract awards for prescription medications, biologics, medical consumables, and specialty pharmaceuticals to Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FUJRN?
SPE2DB25FUJRN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 20, 2025.
How much is contract SPE2DB25FUJRN worth?
The government has obligated $7,532 on SPE2DB25FUJRN.
Is contract SPE2DB25FUJRN an order under another contract?
Yes. SPE2DB25FUJRN is a delivery order under SPE2DB25D9365, an indefinite delivery contract.
Was contract SPE2DB25FUJRN competed?
The extent of competition for SPE2DB25FUJRN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award